Cross-reference: "lidocaine" — FDA ADE reports ↔ evidence literature
A structural index linking the evidence layer (Europe PMC literature topics) and the FDA adverse-event (ADE) layer (openFDA animal-drug reports) by shared mention of the term "lidocaine". No new data was fetched; this topic is derived entirely from existing in-repo topics.
FDA ADE report topic
ade_lidocaine_adverse_events— FDA ADE reports for Lidocaine (active ingredient) — total reports, species & reaction breakdown
Evidence topics referencing "lidocaine"
evidence_exotic_rabbit_toxicology— Evidence cluster — Rabbit (Oryctolagus cuniculus) toxicology (peer-reviewed, Europe PMC)evidence_exotic_sugar_glider_clinical— Evidence cluster — Sugar glider (Petaurus breviceps) clinical cases (peer-reviewed, Europe PMC)
Honest scope note
This is a term-co-occurrence cross-reference: the evidence topics above contain the term "lidocaine" in their text, and the ADE topic aggregates FDA adverse-event reports for that active ingredient. Co-occurrence is not a clinical assertion that the literature studies the drug's adverse events. Verify against the linked source topics before drawing conclusions.